Genomic study targets schizophrenia

An international study involving Irish scientists sheds new light on the biology underlying schizophrenia.

Researchers identified multiple genes and pathways that could “kickstart” new approaches to treatment.

Scientists at Trinity College Dublin played a role in identifying over 100 locations in the human genome associated with the risk of developing schizophrenia. The study, published in Nature, is the largest genomic study published on any psychiatric disorder to date. The findings could lead to new approaches to treating the disorder where there has been little innovation in drug development in more than 60 years.